The roles played by arachidonic acid and its cyclooxygenase (COX)-generated and lipoxygenase (LOX)-generated metabolites have been studied using rodent islets and insulin-secreting cell lines, but very little is known about COX and LOX isoform expression and the effects of modulation of arachidonic acid generation and metabolism in human islets. We have used RT-PCR to identify mRNAs for cytosolic phospholipase A 2 (cPLA 2 ), COX-1, COX-2, 5-LOX, and 12-LOX in isolated human islets. COX-3 and 15-LOX were not expressed by human islets. Perifusion experiments with human islets indicated that PLA 2 inhibition inhibited glucose-stimulated insulin secretion, whereas inhibitors of COX-2 and 12-LOX enzymes enhanced basal insulin secretion and also secretory responses induced by 20 mmol/l glucose or by 50 mol/l arachidonic acid. Inhibition of COX-1 with 100 mol/l acetaminophen did not significantly affect glucose-stimulated insulin secretion. These data indicate that the stimulation of insulin secretion from human islets in response to arachidonic acid does not require its metabolism through COX-2 and 5-/12-LOX pathways. The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of -cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize -cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels. Diabetes 56:197-203, 2007 P hospholipases A 2 (PLA 2 ) constitute a large family of enzymes that hydrolyze the sn-2 position of membrane phospholipids to generate arachidonic acid. Secretory type I (1) and type II (1,2) PLA 2 enzymes have been identified in islets, as have the Ca 2ϩ -dependent type IV cytosolic PLA 2 (cPLA 2 ) (1-3) and the Ca 2ϩ -independent type VI isozymes (4), and it is well-established that insulin secretion from pancreatic -cells is stimulated by arachidonic acid (5-7). Although arachidonic acid is known to exert direct functional effects in vitro, it is also further metabolized by cyclooxygenase (COX) enzymes to produce prostaglandins (rev. in 8) and lipoxygenases (LOX) to produce hydroxyeicosatetraenoic acids (HETEs) and leukotrienes (rev. in 9). Two COX genes have been cloned: the COX-1 gene codes for COX-1 and the COX-3 splice variant (10), and the COX-2 gene codes for the COX-2 isoform. Depending on the oxygenation site in arachidonic acid, the LOX enzymes are termed 5-, 12-, and 15-LOX.The roles played by COX and LOX enzymes in -cells have not been fully established, but there is good evidence that both COX-2 (11-14) and 12-LOX (15,16) play roles in cytokine-mediated damage of -cells. Furthermore, signaling through the 12-LOX pathway is reported to upregulate COX-2 gene expression (17).Although there are some contradictory reports about the effects of COX and LOX products on insulin secretion, the consensus view is that prostaglandins (particularly prostaglandin E 2 [PGE 2 ]) have inhibitory effects, whereas HETEs and leukotrienes are stimulator...